Naughty Flicks

Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenuWarren Buffett disciple Guy Spier built career on value investing. A rare cancer changed everything2 hours agowatch nowCNBC Cures: Value investor Guy Spier on what really mattersan hour agowatch nowBuffett disciple Guy Spier’s rare cancer changed what he values most3 hours agoReplimune to resubmit twice rejected drug for approval after FDA shakeupFri, May 29th 2026Cavs owner Dan Gilbert turns grief over son’s rare disease into search for cureThu, May 28th 2026From rare spinal disease to dancing, how one tiny patient is living a full lifeTue, May 26th 2026watch nowwatch nowVIDEO31:37What’s not to like? Billionaire Dan Gilbert’s rare family storyThu, May 21st 2026watch nowwatch nowVIDEO05:21CNBC Cures: Dan Gilbert on his son’s fight with neurofibromatosisThu, May 21st 2026

More in CNBC Cures

Rare disease families find roadmap to drug development at bootcampsRyan AnastasioThu, May 7th 2026watch nowVIDEO07:10CNBC Cures: Ultragenyx CEO Emil Kakkis on rare disease bootcamp, road to profitabilityThu, May 7th 2026watch nowVIDEO02:18A rare disease ‘bootcamp’ that teaches families how to develop their own drugsThu, May 7th 2026watch nowVIDEO12:56Watch CNBC’s full interview with FDA Commissioner Marty MakaryTue, May 5th 2026watch nowVIDEO02:22CNBC Cures: Selma Blair’s diagnostic odysseyMon, Apr 27th 2026watch nowVIDEO33:28Joy in visibility: Selma Blair’s MS journeyBecky Quick|Katie KramerMon, Apr 27th 2026watch nowVIDEO08:05Regeneron CEO on first-ever FDA approved gene therapy to restore hearingFri, Apr 24th 2026Regeneron weighs overseas price for Otarmeni, gene therapy for rare type of hearing lossAngelica PeeblesFri, Apr 24th 2026watch nowVIDEO12:23Watch CNBC’s full interview with Regeneron CEO Leonard SchleiferFri, Apr 24th 2026A rare disease left her partially paralyzed, now she’s running the Boston MarathonBrad QuickMon, Apr 20th 2026watch nowVIDEO08:06Biotech turns 50: BIO CEO John Crowley on the future of biotech innovationsTue, Apr 21st 2026watch nowVIDEO02:32CNBC Cures: A runner’s rare disease journeyMon, Apr 20th 2026watch nowVIDEO02:04Clean energy executive returns to Boston Marathon after rare disease left her partially paralyzedMon, Apr 20th 2026A mom and tech entrepreneur building AI advocate for rare-disease families like hersIan ThomasMon, Apr 13th 2026CNBC Cures: A dad and a doctor on how raising a child with Angelman syndrome changed himThu, Apr 9th 2026Every Cure’s drug repurposing strategy isn’t what you think, and could change rare disease treatmentBrad QuickTue, Mar 31st 2026watch nowVIDEO42:59How families are defying rare disease | CNBC Full DocumentaryBecky Quick|Kelly LinMon, Apr 20th 2026watch nowVIDEO02:23OpenAI’s Fidji Simo takes medical leave, company announces leadership changesMon, Apr 6th 2026watch nowVIDEO35:58Tailor-made: The world’s first personalized gene-editing treatmentBecky Quick|Katie KramerWed, Apr 1st 2026How CNBC Cures is bringing rare disease stories to a national audienceBrad QuickFri, Mar 20th 2026watch nowVIDEO01:35CNBC Cures: Taking a rare riskFri, Mar 20th 2026watch nowVIDEO04:02‘CNBC Cures: Defying Rare Disease’ premieres tonight at 7 p.m. ETThu, Mar 19th 2026watch nowVIDEO02:21‘Defying rare disease’: CNBC Cures documentary premieres Thursday at 7 p.m. ETWed, Mar 18th 2026watch nowVIDEO01:59‘CNBC Cures: Defying Rare Disease’ premieres Thursday at 7 p.m. ETTue, Mar 17th 2026

About The Author

admin

See author's posts